More importantly, the protein expression of ARL4C was significantly increased by exposure to Wnt agonist 1, thus suggesting that the expression of ARL4C in ccRCC cells is involved in the Wnt signaling pathway. Here, ARL4C is linked to nonpapillary renal cell carcinoma.